![]() |
|
|
Vol. 296, Issue 1, 175-180, January 2001
University of Kentucky College of Pharmacy, Division of
Pharmaceutical Sciences, Lexington, Kentucky (P.M.G., E.W.P., P.J.M.);
Hoffman LaRoche, Inc., Department of Clinical Pharmacology, Nutley, New
Jersey (C.Y.O.); and University of Kentucky College of Medicine,
Department of Pediatrics, Lexington, Kentucky (J.A.M.)
The purpose of these studies was to further elucidate the active
mammary epithelial transport processes for the organic cation cimetidine and the organic anion nitrofurantoin and to determine which
of the identified rat organic anion (rOATs) and organic cation (rOCTs)
transporters may be responsible for transport of these drugs into milk.
Milk-to-serum ratios (M/S) were predicted in vitro for nitrofurantoin,
p-aminohippurate (PAH), and probenecid, and were
compared with the observed M/S values. Groups of six lactating female
rats received intravenous infusions of cimetidine, nitrofurantoin, PAH,
or probenecid alone and with another agent. Steady-state milk and serum
concentrations were measured by high performance liquid
chromatography. Reverse transcriptase-polymerase chain reaction
was performed to detect rOATs and rOCTs in livers, kidneys, and mammary
glands of lactating rats. Nitrofurantoin and probenecid were actively
transported into rat milk with an M/S 100- and 4.7-fold greater than
predicted, respectively, but predicted and observed M/S values for PAH
were similar. The cimetidine infusion did not alter nitrofurantoin M/S.
Nitrofurantoin significantly decreased M/S of cimetidine (26.6 ± 4.9 versus 17.7 ± 5.6). Probenecid did not alter the M/S of
nitrofurantoin, or PAH, but increased the M/S of cimetidine from
15.5 ± 3.6 to 21.5 ± 7.7. Of the six transporter genes,
evidence of expression in lactating rat mammary tissue was found for
only rOCT1 and rOCT3. The results suggest different secretory transport
systems for cimetidine, nitrofurantoin, and probenecid, but that
passive diffusion governs PAH passage into milk. The products of rOCT1
and rOCT3 might transport these drugs into milk.
This article has been cited by other articles:
![]() |
L. Wang, M. Leggas, M. Goswami, P. E. Empey, and P. J. McNamara N-(4-[2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine Carboxamide (GF120918) As a Chemical ATP-Binding Cassette Transporter Family G Member 2 (Abcg2) Knockout Model to Study Nitrofurantoin Transfer into Milk Drug Metab. Dispos., December 1, 2008; 36(12): 2591 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vore and M. Leggas Progesterone Acts via Progesterone Receptors A and B to Regulate Breast Cancer Resistance Protein Expression Mol. Pharmacol., March 1, 2008; 73(3): 613 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kwok, A. Yamauchi, R. Rajesan, L. Chan, U. Dhillon, W. Gao, H. Xu, B. Wang, S. Takahashi, J. Semple, et al. Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R793 - R802. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Merino, J. W. Jonker, E. Wagenaar, A. E. van Herwaarden, and A. H. Schinkel The Breast Cancer Resistance Protein (BCRP/ABCG2) Affects Pharmacokinetics, Hepatobiliary Excretion, and Milk Secretion of the Antibiotic Nitrofurantoin Mol. Pharmacol., May 1, 2005; 67(5): 1758 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Gerk, J. A. Moscow, and P. J. McNamara BASOLATERAL ACTIVE UPTAKE OF NITROFURANTOIN IN THE CIT3 CELL CULTURE MODEL OF LACTATION Drug Metab. Dispos., June 1, 2003; 31(6): 691 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alcorn and P. J. McNamara Acyclovir, Ganciclovir, and Zidovudine Transfer into Rat Milk Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1831 - 1836. [Abstract] [Full Text] [PDF] |
||||